Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912122031> ?p ?o ?g. }
- W2912122031 endingPage "110" @default.
- W2912122031 startingPage "98" @default.
- W2912122031 abstract "Cholangiocarcinoma (CCA) is one of the most common fatal carcinomas and is well known to be lack of effective treatment. Thus, novel therapeutic strategies are greatly needed. Evodiamine, a quinozole alkaloid isolated from evodia rutaecarpa Bentham, has been demonstrated to exhibit anti-tumor effects on many cancer cells. However, little is known in terms of the effects on cholangiocarcinoma. In this study, we studied whether this traditional Chinese Medicine could serve as new potential therapeutic drugs to treat CCA. We discovered that evodiamine inhibited CCA cell proliferation and induced apoptosis. Moreover, evodiamine inhibited CCA cell migration and invasion. Mechanistically, our studies demonstrated that evodiamine inhibited the activation of IL-6 -induced STAT3 signaling activation, and the inhibitory effect was likely due to the upregulation of phosphatase shatterproof 2 (SHP-2), a negative feedback regulator of IL-6/STAT3. Blockage of SHP-2 through small interference RNA (siRNA) abolished the evodiamine -induced IL-6/STAT3 signaling inhibition. Moreover, in vivo experiment showed evodiamine inhibited the tumor growth of nude mice bearing TFK-1 xenografts. In summary, our results implied evodiamine as a promising anti-cancer agent in the treatment of CCA, and the mechanism is likely due to the inhibition of IL-6/STAT3 signaling with upregulating the expression levels of SHP-2." @default.
- W2912122031 created "2019-02-21" @default.
- W2912122031 creator A5011297387 @default.
- W2912122031 creator A5023363049 @default.
- W2912122031 creator A5023933073 @default.
- W2912122031 creator A5036278731 @default.
- W2912122031 creator A5037337693 @default.
- W2912122031 creator A5059125345 @default.
- W2912122031 creator A5060282020 @default.
- W2912122031 creator A5077537812 @default.
- W2912122031 creator A5083579026 @default.
- W2912122031 date "2019-03-01" @default.
- W2912122031 modified "2023-10-14" @default.
- W2912122031 title "Induction of phosphatase shatterproof 2 by evodiamine suppresses the proliferation and invasion of human cholangiocarcinoma" @default.
- W2912122031 cites W1036087850 @default.
- W2912122031 cites W1805043225 @default.
- W2912122031 cites W1964081206 @default.
- W2912122031 cites W1979683878 @default.
- W2912122031 cites W1981223981 @default.
- W2912122031 cites W1986707731 @default.
- W2912122031 cites W1992806448 @default.
- W2912122031 cites W1995732721 @default.
- W2912122031 cites W1995850023 @default.
- W2912122031 cites W1997641466 @default.
- W2912122031 cites W1998633004 @default.
- W2912122031 cites W2007840001 @default.
- W2912122031 cites W2014199817 @default.
- W2912122031 cites W2015182899 @default.
- W2912122031 cites W2018322688 @default.
- W2912122031 cites W2023160025 @default.
- W2912122031 cites W2036074013 @default.
- W2912122031 cites W2044724701 @default.
- W2912122031 cites W2044764720 @default.
- W2912122031 cites W2058901939 @default.
- W2912122031 cites W2069100318 @default.
- W2912122031 cites W2075255898 @default.
- W2912122031 cites W2079931904 @default.
- W2912122031 cites W2089915548 @default.
- W2912122031 cites W2104268053 @default.
- W2912122031 cites W2107038478 @default.
- W2912122031 cites W2111361573 @default.
- W2912122031 cites W2113231588 @default.
- W2912122031 cites W2127833800 @default.
- W2912122031 cites W2132072835 @default.
- W2912122031 cites W2136848887 @default.
- W2912122031 cites W2145228970 @default.
- W2912122031 cites W2146764459 @default.
- W2912122031 cites W2156555850 @default.
- W2912122031 cites W2174619268 @default.
- W2912122031 cites W2175576302 @default.
- W2912122031 cites W2199206894 @default.
- W2912122031 cites W2228056930 @default.
- W2912122031 cites W2264711365 @default.
- W2912122031 cites W2273649406 @default.
- W2912122031 cites W2289284908 @default.
- W2912122031 cites W2482036772 @default.
- W2912122031 cites W2554359977 @default.
- W2912122031 cites W2566551851 @default.
- W2912122031 cites W2597258638 @default.
- W2912122031 cites W2601725049 @default.
- W2912122031 cites W2604648767 @default.
- W2912122031 cites W2604888516 @default.
- W2912122031 cites W2607351395 @default.
- W2912122031 cites W2612276437 @default.
- W2912122031 cites W2616821940 @default.
- W2912122031 cites W2728990023 @default.
- W2912122031 cites W2735058979 @default.
- W2912122031 cites W2740173227 @default.
- W2912122031 cites W2740790577 @default.
- W2912122031 cites W2742556528 @default.
- W2912122031 cites W2743896081 @default.
- W2912122031 cites W2743914929 @default.
- W2912122031 cites W2745215964 @default.
- W2912122031 cites W2759154444 @default.
- W2912122031 cites W2759206384 @default.
- W2912122031 cites W2761494335 @default.
- W2912122031 cites W2763492611 @default.
- W2912122031 cites W2772832223 @default.
- W2912122031 cites W2855832140 @default.
- W2912122031 cites W4233651354 @default.
- W2912122031 cites W4380533045 @default.
- W2912122031 doi "https://doi.org/10.1016/j.biocel.2019.01.012" @default.
- W2912122031 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30682488" @default.
- W2912122031 hasPublicationYear "2019" @default.
- W2912122031 type Work @default.
- W2912122031 sameAs 2912122031 @default.
- W2912122031 citedByCount "17" @default.
- W2912122031 countsByYear W29121220312019 @default.
- W2912122031 countsByYear W29121220312020 @default.
- W2912122031 countsByYear W29121220312021 @default.
- W2912122031 countsByYear W29121220312022 @default.
- W2912122031 countsByYear W29121220312023 @default.
- W2912122031 crossrefType "journal-article" @default.
- W2912122031 hasAuthorship W2912122031A5011297387 @default.
- W2912122031 hasAuthorship W2912122031A5023363049 @default.
- W2912122031 hasAuthorship W2912122031A5023933073 @default.
- W2912122031 hasAuthorship W2912122031A5036278731 @default.
- W2912122031 hasAuthorship W2912122031A5037337693 @default.